These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19001462)

  • 21. Commentary: how serious is getting a diagnosis of prostate cancer?
    Barry MJ
    Oncologist; 2008 Mar; 13(3):306-8. PubMed ID: 18378541
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What will the emperor say? Screening for prostate cancer as of 2008.
    Concato J
    Cancer J; 2009; 15(1):7-12. PubMed ID: 19197166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate specific antigen screening and active surveillance in the elderly.
    Konety BR
    J Urol; 2009 Apr; 181(4):1534-5. PubMed ID: 19230925
    [No Abstract]   [Full Text] [Related]  

  • 25. [Detection of prostate cancer].
    Seitz M; Stanislaus P; Stief C
    MMW Fortschr Med; 2008 Jul; 150(28-31):39-41, 43. PubMed ID: 19006891
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men.
    Capitanio U; Perrotte P; Hutterer GC; Suardi N; Jeldres C; Shariat SF; Duclos A; Arjane P; Montorsi F; Karakiewicz PI
    Int J Urol; 2009 Jan; 16(1):91-5. PubMed ID: 19054167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prostate cancer epidemiology].
    Beuzeboc P;
    Soins; 2007 Mar; (713):32-3. PubMed ID: 17419566
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 2008;54:262-73.
    Kvåle R; Hernes E; Bray F
    Eur Urol; 2009 May; 55(5):e88-9; author reply e90-1. PubMed ID: 19062155
    [No Abstract]   [Full Text] [Related]  

  • 29. Nomograms for prostate cancer--is their use evidence-based?
    Stapleton AM; Pinnock CB
    Nat Clin Pract Urol; 2005 Oct; 2(10):462-3. PubMed ID: 16474602
    [No Abstract]   [Full Text] [Related]  

  • 30. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
    Barry MJ; Mulley AJ
    J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
    [No Abstract]   [Full Text] [Related]  

  • 31. In this issue: mini-theme on geriatric care and cancer screening.
    Bowman MA; Neale AV
    J Am Board Fam Med; 2009; 22(3):231-3. PubMed ID: 19429726
    [No Abstract]   [Full Text] [Related]  

  • 32. What would you do, doctor?
    Smith JA
    J Urol; 2009 Aug; 182(2):421-2. PubMed ID: 19524982
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.
    Jansen FH; Roobol M; Jenster G; Schröder FH; Bangma CH
    Eur Urol; 2009 Mar; 55(3):563-74. PubMed ID: 19058905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A life-changing event.
    Palmer K
    Minn Med; 2005 Jun; 88(6):28-9. PubMed ID: 16050304
    [No Abstract]   [Full Text] [Related]  

  • 35. The Cochrane Health Promotion and Public Health Field--expanding and promoting the evidence base.
    Doyle J; Waters E
    Promot Educ; 2002; 9(3):96-7, 116, 127. PubMed ID: 12426970
    [No Abstract]   [Full Text] [Related]  

  • 36. 15-year followup of a population based prostate cancer screening study.
    Kjellman A; Akre O; Norming U; Törnblom M; Gustafsson O
    J Urol; 2009 Apr; 181(4):1615-21; discussion 1621. PubMed ID: 19233435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Elevated PSA--what to do?].
    Machemer H; Rohde D
    MMW Fortschr Med; 2008 Oct; 150(44):38-9. PubMed ID: 19024490
    [No Abstract]   [Full Text] [Related]  

  • 38. Prostate cancer screening: the continuing controversy.
    Wilbur J
    Am Fam Physician; 2008 Dec; 78(12):1377-84. PubMed ID: 19119557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and treatment of prostate cancer. Beyond the controversy over whether and whom to screen, the appropriate method of screening is also subject to debate.
    Loeb S; Catalona WJ
    Med Econ; 2008 Dec; 85(24):36-41. PubMed ID: 19209648
    [No Abstract]   [Full Text] [Related]  

  • 40. Uncertainty and quality of life among men undergoing active surveillance for prostate cancer in the United States and Ireland.
    Hegarty JM; Wallace M; Comber H
    Am J Mens Health; 2008 Jun; 2(2):133-42. PubMed ID: 19477777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.